MPM BioImpact LLC

Q3 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
37
Total value ($000)
$1,347,706
Net value change ($000)
-292,251 (-17.8%)
New positions
9
Sold out positions
10
Turnover %
43.5%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IOVA 42,026 NEW
IMCR 36,448 NEW
VIR 31,413 NEW
VSTM 31,005 NEW
Odyssey Therapeutics, Inc. 28,644 NEW
ORKA 24,987 NEW
ACRS 21,722 393.9%
NGNE 21,473 NEW
NTRA 12,293 48.9%
CRBP 11,371 NEW
Top Reduces (Value $000, Stocks/ETFs)
RVMD -92,232 -100.0%
LQDA -69,890 -63.2%
AKTS -61,706 -39.6%
ALMS -56,815 -100.0%
RARE -47,354 -100.0%
DNTH -40,942 -100.0%
MLTX -31,288 -100.0%
SNDX -29,151 -100.0%
CGEM -27,989 -15.8%
BIOA -27,710 -67.8%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 48,627 (3.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type